Login / Signup

Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015-2020.

Oliver Van OekelenNicole BirrerWilliam WessonVincent L GalateEdward Robert Scheffer CliffAaron M GoodmanAl-Ola AbdallahRajshekhar ChakrabortyVinay PrasadGhulam Rehman Mohyuddin
Published in: Blood cancer journal (2022)
Keyphrases
  • clinical trial
  • multiple myeloma
  • newly diagnosed
  • phase ii
  • randomized controlled trial
  • double blind